[Form 4] CLARIVATE PLC Insider Trading Activity

Rhea-AI Filing Summary

Clarivate plc (CLVT): Director transaction disclosed. Andrew M. Snyder reported purchasing 1,460,000 ordinary shares on 10/31/2025 at a weighted average price of $3.33. The filing notes the trade prices ranged from $3.25 to $3.40, with full breakdowns available upon request.

Following the transaction, Snyder reported beneficial ownership across multiple accounts: 2,247,510 shares indirectly through Cambridge Information Group I LLC; 177,451 shares held directly; 10,489,466 shares indirectly through Cambridge Information Group II LLC; 4,033,271 shares indirectly through Cambridge Information Group III LLC; 8,821,984 shares indirectly through Cambridge Information Group Inc.; 3,417 shares indirectly through CSA GP Corporation; and 238,500 shares indirectly through the Snyder 2011 Family Trust. He disclaims beneficial ownership except to the extent of his pecuniary interest.

Insights

Equity Ownership & Governance Analyst

Director-linked entities purchased 1,460,000 shares at a weighted average of $3.33; ownership remains largely indirect with standard disclaimers.

The filing reports a purchase (code "P") of 1,460,000 Ordinary Shares on 10/31/2025 at a weighted average price of $3.33 (range $3.25–$3.40). Following the transaction, one reporting line shows 2,247,510 shares held indirectly by Cambridge Information Group I LLC. Additional indirect holdings are listed for other entities, including Cambridge Information Group II LLC (10,489,466), Cambridge Information Group III LLC (4,033,271), Cambridge Information Group Inc. (8,821,984), CSA GP Corporation (3,417), and the Snyder 2011 Family Trust (238,500). A direct holding of 177,451 shares is also shown.

Footnotes state the reported price is a weighted average, with trade details available upon request, and clarify that Andrew M. Snyder’s beneficial ownership is disclaimed except to the extent of his pecuniary interest. The filing identifies Snyder as a Director, and indicates the indirect holdings arise through entities managed by or related to Cambridge Information Group.

This is a change in insider beneficial ownership, not an operational or financing event. Items to watch include any subsequent Form 4s that alter these balances, potential 10b5-1 plan indications in future filings, and year-end Section 16 reports. The next meaningful checkpoint would be subsequent insider filings or periodic reports referencing ownership as of later 2025/2026 dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Snyder Andrew Miles

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST MARY AXE

(Street)

LONDON X0 EC3A 8BE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/31/2025		P		1,460,000	A	$3.33(1)	2,247,510	I	By Cambridge Information Group I LLC(2)
Ordinary Shares								177,451	D
Ordinary Shares								10,489,466	I	By Cambridge Information Group II LLC(2)
Ordinary Shares								4,033,271	I	By Cambridge Information Group III LLC(2)
Ordinary Shares								8,821,984	I	By Cambridge Information Group Inc.(2)
Ordinary Shares								3,417	I	By CSA GP Corporation(2)
Ordinary Shares								238,500	I	By Snyder 2011 Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. The prices ranged from $3.25 to $3.40, inclusive. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

2. Andrew M. Snyder is the Chief Executive Officer of and a shareholder in Cambridge Information Group Inc. ("CIG"), which acts as manager of Cambridge Information Group I LLC, Cambridge Information Group II LLC and Cambridge Information Group III LLC. CSA GP Corporation is a wholly owned subsidiary of CIG. Mr. Snyder disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

3. Andrew M. Snyder serves as a trustee and is one of the beneficiaries of the Snyder 2011 Family Trust. Mr. Snyder disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CLVT director Andrew M. Snyder report on Form 4?

He purchased 1,460,000 ordinary shares on 10/31/2025 at a weighted average price of $3.33.

What price range applied to the CLVT share purchases?

Trades occurred between $3.25 and $3.40, inclusive, with details available upon request.

How many CLVT shares does Snyder report owning directly after the trade?

He reports 177,451 shares held directly.

What are Snyder’s reported indirect CLVT holdings after the trade?

Reported indirect amounts include 2,247,510 (CIG I LLC), 10,489,466 (CIG II LLC), 4,033,271 (CIG III LLC), 8,821,984 (CIG Inc.), 3,417 (CSA GP Corp.), and 238,500 (Snyder 2011 Family Trust).

Does Snyder claim full beneficial ownership of the indirect holdings?

He disclaims beneficial ownership except to the extent of his pecuniary interest.

Was the transaction potentially under a Rule 10b5-1 plan?

The form provides a checkbox for Rule 10b5-1(c); the presence of the checkbox is noted in the form’s header.